|
US5110795A
|
|
Methods and compositions for the treatment of inflammatory bowel diseases and conditions
|
|
WO8907449A1
|
|
Methods for treating immunoinflammatory and other disease conditions
|
|
CA1335347C
|
|
Methods and compositions for the treatment of non-ige-mediated diseases
|
|
US5061692A
|
|
Methods and compositions for the treatment of non-IgE-mediated diseases
|
|
US4816449A
|
|
Immunotherapeutic anti-inflammatory peptide agents
|
|
US4752601A
|
|
Method of blocking immune complex binding to immunoglobulin FC receptors
|
|
US4753927A
|
|
Method of blocking immune complex binding to immunoglobulin Fc receptors
|
|
NZ209189A
|
|
Immunotherapeutic peptides, with amino acid sequence derived from immunoglobulin active site; pharmaceutical compositions
|
|
US4692511A
|
|
Peptide antagonists for the C5a anaphylatoxin
|
|
US4579840A
|
|
Method of blocking immune complex binding to immunoglobulin Fc receptors
|
